|
⚲
|
| Keyboard |
| GV 2017 LP
✚
|
|
|---|---|
| CIK # | 0001733340 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001733340] | |
| 4 | [0001733340] | |
| SC 13G | [0001733340] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| GV 2017 LP | Verve Therapeutics Inc | [2022-02-14] |
| GV 2017 LP | Gitlab Inc | [2022-02-14] |
| GV 2017 LP | Benson Hill Inc | [2022-02-14] |
| GV 2017 LP | TScan Therapeutics Inc | [2022-02-14] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| GV 2017 LP | |
| GV 2019 GP LLC | |
| GV 2019 GP LP | |
| GV 2021 GP LP | |
| Ethos Technologies Inc | |
| GV 2019 LP | |
| Alphabet Inc | |
| GV 2017 GP LP | |
| GV 2021 LP | |
| GV 2021 GP LLC | |
| View All | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ethos Technologies Inc LIFE
Class A Common Stock
|
2026-01-30 | Sell | 1,755,632 | $19.00 | 33,357,008 |
|
Ethos Technologies Inc LIFE
Class A Common Stock
|
2026-01-30 | Sell | 89,676 | $19.00 | 1,703,844 |
|
Ethos Technologies Inc LIFE
Class A Common Stock
|
2026-01-30 | Conversion | 1,755,632 | ||
|
Ethos Technologies Inc LIFE
Series B Preferred Stock · derivative
|
2026-01-30 | Conversion | 1,751,791 | ||
|
Ethos Technologies Inc LIFE
Series D Preferred Stock · derivative
|
2026-01-30 | Conversion | 552,126 | ||
|
Ethos Technologies Inc LIFE
Series C Preferred Stock · derivative
|
2026-01-30 | Conversion | 3,287,925 | ||
|
Ethos Technologies Inc LIFE
Class A Common Stock
|
2026-01-30 | Conversion | 3,287,925 | ||
|
Ethos Technologies Inc LIFE
Class A Common Stock
|
2026-01-30 | Conversion | 571,907 | ||
|
Verve Therapeutics Inc VERV
Common Stock
|
2025-07-25 | Tender | 4,260,047 | ||
|
Verve Therapeutics Inc VERV
Common Stock
|
2025-07-25 | Tender | 6,108,442 | ||
|
Verve Therapeutics Inc VERV
Common Stock
|
2025-07-25 | Tender | 1,800,000 | ||
|
Verve Therapeutics Inc VERV
Common Stock
|
2022-11-04 | Sell | 242 | $32.90 | 7,962 |
|
Verve Therapeutics Inc VERV
Common Stock
|
2022-11-04 | Sell | 651 | $31.99 | 20,825 |
|
Verve Therapeutics Inc VERV
Common Stock
|
2022-11-04 | Sell | 243 | $32.90 | 7,995 |
|
Verve Therapeutics Inc VERV
Common Stock
|
2022-11-04 | Sell | 650 | $31.99 | 20,794 |
|
Verve Therapeutics Inc VERV
Common Stock
|
2022-11-04 | Sell | 47,690 | $31.12 | 1,484,113 |
|
Verve Therapeutics Inc VERV
Common Stock
|
2022-11-04 | Sell | 47,690 | $31.12 | 1,484,113 |
|
Verve Therapeutics Inc VERV
Common Stock
|
2022-11-04 | Other | 48,583 | $0.00 | |
|
Verve Therapeutics Inc VERV
Common Stock
|
2022-11-03 | Other | 49,569 | $0.00 | |
|
Verve Therapeutics Inc VERV
Common Stock
|
2022-11-03 | Sell | 22,279 | $32.32 | 720,057 |
| showing 20 of 57 most recent transactions | |||||